Publisher: DelveInsight
Category: Cancer Treatment

Cancer Treatment market research reports by DelveInsight

(480 reports matching your criteria)
    • Adult T-Cell Leukemia-Lymphoma - Epidemiology Forecast to 2032

      DelveInsight's "" Adult T-Cell Leukemia-Lymphoma - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Adult T-Cell Leukemia-Lymphoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United ... Read More

    • Chronic Myelocytic Leukemia (CML) - Epidemiology Forecast to 2032

      DelveInsight's "" Chronic Myelocytic Leukemia (CML) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Chronic Myelocytic Leukemia (CML) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the U ... Read More

    • Renal cell carcinoma - Epidemiology Forecast to 2032

      DelveInsight's "" Renal cell carcinoma - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Renal cell carcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. ... Read More

    • Recurrent or Metastatic Head and Neck cancer - Epidemiology Forecast to 2032

      DelveInsight's "" Recurrent or Metastatic Head and Neck cancer - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Recurrent or Metastatic Head and Neck cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, It ... Read More

    • Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) - Epidemiology Forecast to 2032

      DelveInsight's "" Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) epidemiology in the 7MM, i.e., the United State ... Read More

    • Microsatellite Stable Colorectal Cancer - Epidemiology Forecast - 2032

      DelveInsight's "" Microsatellite Stable Colorectal Cancer - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Microsatellite Stable Colorectal Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, Franc ... Read More

    • Relapsed Chronic Lymphocytic Leukemia (CLL) - Epidemiology Forecast to 2032

      DelveInsight's "" Relapsed Chronic Lymphocytic Leukemia (CLL) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Relapsed Chronic Lymphocytic Leukemia (CLL) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Ital ... Read More

    • Chronic Lymphocytic Leukemia (CLL) - Epidemiology Forecast to 2032

      DelveInsight's "" Chronic Lymphocytic Leukemia (CLL) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Chronic Lymphocytic Leukemia (CLL) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the ... Read More

    • BRAF-Mutant Metastatic Melanoma - Epidemiology Forecast to 2032

      DelveInsight's "" BRAF-Mutant Metastatic Melanoma - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted BRAF-Mutant Metastatic Melanoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the Unite ... Read More

    • HER2-Negative Breast Cancer - Epidemiology Forecast to 2032

      DelveInsight's "" HER2-Negative Breast Cancer - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted HER2-Negative Breast Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdo ... Read More

    • Low-Grade Upper Tract Urothelial Cancer (LG UTUC) - Epidemiology Forecast to 2032

      DelveInsight's "" Low-Grade Upper Tract Urothelial Cancer (LG UTUC) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Low-Grade Upper Tract Urothelial Cancer (LG UTUC) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, ... Read More

    • Human Papillomavirus-positive Oropharyngeal Cancer - Epidemiology Forecast - 2032

      DelveInsight's "" Human Papillomavirus-positive Oropharyngeal Cancer - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Human Papillomavirus-positive Oropharyngeal Cancer epidemiology in the 7MM, i.e., the United States, EU5 (German ... Read More

    • NK Cell therapies - Pipeline Insight, 2022

      “ NK Cell therapy - Pipeline Insight, 2022 ” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in NK Cell therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment b ... Read More

    • ESR1 Mutated Metastatic Breast Cancer - Market Insight, Epidemiology and Market Forecast -2032

      DelveInsight's "" ESR1 Mutated Metastatic Breast Cancer- Market Insights, Epidemiology, and Market Forecast-2032 "" report delivers an in-depth understanding of the ESR1 Mutated Metastatic Breast Cancer, historical and forecasted epidemiology as well as the ESR1 Mutated Metastatic Breast Cancer mark ... Read More

    • Metastatic HER2 positive breast cancer - Epidemiology Forecast to 2032

      DelveInsight's "" Metastatic HER2 positive breast cancer - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Metastatic HER2 positive breast cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, ... Read More

    • Advanced Urothelial Carcinoma - Epidemiology Forecast - 2032

      DelveInsight's "" Advanced Urothelial Carcinoma - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Advanced Urothelial Carcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Ki ... Read More

    • Recurrent or Metastatic Nasopharyngeal Carcinoma - Epidemiology Forecast - 2032

      DelveInsight's "" Recurrent or Metastatic Nasopharyngeal Carcinoma - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Recurrent or Metastatic Nasopharyngeal Carcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, S ... Read More

    • Liquid Biopsy for Cancer Diagnostics – Competitive Landscape and Pipeline Analysis, 2022

      DelveInsight’s, “ Liquid Biopsy for Cancer Diagnostics – Competitive Landscape and Pipeline Analysis, 2022 ,” report provides an understanding of the current competition, pipeline products, and changing market dynamics of the Liquid Biopsy for Cancer Diagnostics market in the 7 major pharmaceutical ... Read More

    • Metastatic Renal Cell Carcinoma (mRCC) - Epidemiology Forecast to 2032

      DelveInsight's "" Metastatic Renal Cell Carcinoma (mRCC) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Metastatic Renal Cell Carcinoma (mRCC) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, ... Read More

    • B-Cell Non-Hodgkin Lymphoma - Epidemiology Forecast to 2032

      DelveInsight's "" B-Cell Non-Hodgkin Lymphoma - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted B-Cell Non-Hodgkin Lymphoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdo ... Read More

    • Urothelial Carcinoma - Epidemiology Forecast to 2032

      DelveInsight's "" Urothelial Carcinoma - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Urothelial Carcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. ... Read More

    • Nevoid Basal Cell Carcinoma Syndrome (NBCCS) - Epidemiology Forecast - 2032

      DelveInsight's "" Nevoid Basal Cell Carcinoma Syndrome (NBCCS) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Nevoid Basal Cell Carcinoma Syndrome (NBCCS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, It ... Read More

    • Neuroendocrine Carcinoma - Epidemiology Forecast to 2032

      DelveInsight's "" Neuroendocrine Carcinoma - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Neuroendocrine Carcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), an ... Read More

    • Surgery and Radiation Therapy in Brain Cancer- Market Insight, Competive Landscape and Market Forecast- 2026

      Surgery and Radiation Therapy in Brain Cancer- Market Insight, Competive Landscape and Market Forecast- 2026 ‘Surgery and Radiation Therapy in Brain Cancer - Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Surgery and Radiation Therapy in ... Read More

    • Checkpoint Inhibitor Refractory Cancer -Epidemiology Forecast 2032

      DelveInsight's "" Checkpoint Inhibitor Refractory Cancer - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Checkpoint Inhibitor Refractory Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, ... Read More

13 14 15 16 17 18 19 20

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings